Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salminen, S. J.
Right arrow Articles by Isolauri, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salminen, S. J.
Right arrow Articles by Isolauri, E.
© 2005 The American Society for Nutritional Sciences J. Nutr. 135:1294-1298, May 2005


Symposium: Innate Immunity and Human Milk

Probiotics That Modify Disease Risk1

Seppo J. Salminen2, Miguel Gueimonde and Erika Isolauri*

Functional Foods Forum and Department of Biochemistry and Food Chemistry, * Department of Pediatrics, University of Turku, Finland

2To whom correspondence should be addressed. E-mail: seppo.salminen{at}utu.fi.

Probiotics are defined as live bacterial preparations with clinically documented health effects in humans. Probiotics have specific properties and targets in the human intestinal tract and intestinal microbiota. Each probiotic strain, independent of its genus and species is unique and, thus, the properties and the human health effects of each strain have to be assessed in a case-by-case manner. Understanding the mechanisms by which probiotics influence the normal intestinal microbiota and counteract aberrancies in microbiota would facilitate the use of probiotics for both dietary management and reduction in risk of specific diseases. Development of intestinal microbiota is an important factor affecting the health of the newborn. Recent studies suggest that specific bacterial components, especially the bifidobacteria, have a key impact on development of a healthy balanced infant microbiota. The composition of infant and child intestinal microbiota may become aberrant and thus influence the development of diarrheal, inflammatory, and allergic diseases. Based on this understanding, positive health effects of probiotics have been reported in the management of diarrheal, inflammatory, and allergic diseases in infants. Most recently, a reduction in risk of atopic diseases followed early administration of specific probiotics.


KEY WORDS: • probiotic • intestinal microbiota • health effects




This article has been cited by other articles:


Home page
Int ImmunolHome page
L. N. Fink, L. H. Zeuthen, H. R. Christensen, B. Morandi, H. Frokiaer, and G. Ferlazzo
Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses
Int. Immunol., December 1, 2007; 19(12): 1319 - 1327.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
B. Sanchez, M.-C. Champomier-Verges, B. Stuer-Lauridsen, P. Ruas-Madiedo, P. Anglade, F. Baraige, C. G. de los Reyes-Gavilan, E. Johansen, M. Zagorec, and A. Margolles
Adaptation and Response of Bifidobacterium animalis subsp. lactis to Bile: a Proteomic and Physiological Approach
Appl. Envir. Microbiol., November 1, 2007; 73(21): 6757 - 6767.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. S. Newburg
Innate Immunity and Human Milk
J. Nutr., May 1, 2005; 135(5): 1308 - 1312.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]